Market Overview

UPDATE: Goldman Sachs Lowers PT on McKesson Corporation Following ABC/WAG Deal

Share:
Related MCK
The Pharma Stocks Vitaliy Katsenelson Is Buying Now
7 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé
CHICAGO TRUST Co NA Buys Discover Financial Services, Dominion Energy Inc, DowDuPont Inc, Sells ... (GuruFocus)

In a report published Wednesday, Goldman Sachs analyst Robert P. Jones reiterated a Buy rating on McKesson Corporation (NYSE: MCK), but lowered the price target from $124.00 to $122.00.

In the report, Jones noted, “On our new estimates, ABC now trades at a 2x P/E multiple premium to MCK and CAH. While some may argue that ABC's valuation is justifiable given growth and support to numbers from the announced WAG deal, we find it difficult to overcome at current levels and maintain our Neutral rating. We still see the greatest risk/reward in MCK trading essentially at parity with CAH on our CY14, given (1) a more attractive growth profile through CY2014 after CAH's loss of WAG, (2) pending CVS contract renewals, which pose a risk for both, but greater for CAH at 31% of sales, versus MCK at 16%, and (3) a more attractive Specialty footprint - a differentiator in outer years.”

McKesson Corporation closed on Tuesday at $106.87.

Latest Ratings for MCK

DateFirmActionFromTo
Oct 2017Cowen & Co.UpgradesMarket PerformOutperform
Sep 2017RBC CapitalInitiates Coverage OnSector Perform
Sep 2017BairdUpgradesNeutralOutperform

View More Analyst Ratings for MCK
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Price Target Analyst Ratings

 

Related Articles (MCK)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...